{"id":"W2598763057","doi":"10.1200/jco.2012.30.15_suppl.3039","title":"MGCD265, a multitargeted oral tyrosine kinase receptor inhibitor of Met and VEGFR: Dose-escalation phase I study.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pyrogenesis (Canada); BC Cancer Agency","funders":"","keywords":"Medicine; Adverse effect; Pharmacodynamics; Pharmacokinetics; Internal medicine; Gastroenterology; Pharmacology; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008238389,0.001354818,0.0010269,0.0005977394,0.000283462,0.0006812597,0.0009291963,0.0009859664,0.001985986],"category_scores_gemma":[0.0002921406,0.0005367067,0.0006485077,0.0005114846,0.0006184221,0.0005046932,0.0003694952,0.001884305,0.0005890336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008198805,"about_ca_system_score_gemma":0.001115882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000844912,"about_ca_topic_score_gemma":0.002338583,"domain_scores_codex":[0.9997819,0.0000660001,0.00001245682,0.00003955788,0.00003934403,0.00006070897],"domain_scores_gemma":[0.9997769,0.00002225393,0.00005387664,0.00001826475,0.00001241843,0.0001163521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3853684,0.1471046,0.01164344,0.002187945,0.001298951,0.001443037,0.000550473,0.01190661,0.1997055,0.001196842,0.01130562,0.2262886],"study_design_scores_gemma":[0.4233646,0.524775,0.01771729,0.00007272574,0.0005375206,0.001429562,0.00007897527,0.003681725,0.02010758,0.0003532993,0.007821733,0.00005990454],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919189,0.001782778,0.000953812,0.0002828614,0.00005801607,0.002272576,0.0008034902,0.0001489481,0.001778695],"genre_scores_gemma":[0.9902791,0.001782185,0.002087528,0.0005880611,0.00007684153,0.001167453,0.001716398,0.00002306167,0.002279354],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001985986,"threshold_uncertainty_score":0.006643832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09979410875692372,"score_gpt":0.4710545838006717,"score_spread":0.3712604750437479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}